Cytokinetics is a biotechnology company that focuses on the development of novel muscle therapeutics

The company is dedicated to discovering and advancing treatments for a range of diseases characterized by muscle weakness and impaired muscle function, notably in conditions such as heart failure and neuromuscular diseases. Cytokinetics utilizes its expertise in muscle biology to create innovative therapies that may enhance muscle performance, improve patient outcomes, and ultimately transform the standard of care in these areas. Through rigorous research and clinical trials, Cytokinetics aims to provide groundbreaking options for patients with unmet medical needs tied to muscle-related disorders.